Aarsland, D., Marsh, L., Schrag, A. (2009). Neuropsychiatric symptoms in Parkinson’s disease. Movement Disorders; Vol. 24, No. 15: 2175-2186.
Ardouin, C., Chéreau, I., Llorca, P.M., Lhommée, E., Durif, F., Pollak, P., Krack, P., pour le groupe évaluation comportementale de la maladie de Parkinson. (2009). Evaluation des troubles comportementaux hyper- et hypodopaminergiques dans la maladie de Parkinson. Revue Neurologique ; 165 : 845-856.
Borg, M. & Bayreuther, C. (2008). Syndrome de dysregulation dopaminergique dans la maladie de Parkinson. Revue Neurologique 164 : 310-321.
Butterfield, L.C., Cimino, C.R., Oekle, L.E., Hauser, R.A., Sanchez-Ramos, J. (2010). The independant influence of apathy and depression on cognitive functioning in Parkinson’s disease. Neuropsychology; 24(6): 721-730.
Cambier, J., Masson, M., Dehen, H., Masson, C. (2008). Neurologie : Abrégés. Elsevier Masson SAS, Issy-les-Moulineaux.
Caviness, J.N., Driver-Dunckley, E., Connor, D.J., Sabbagh, M.N., Hentz, J.G., Noble, B., Evidente, V.G.H., Shill, H.A., Adler, C.H. (2007). Defining Mild Cognitive Impairment in Parkinson’s disease. Movement Disorders; Vol. 22, No. 9: 1272-1277.
Defebvre, L. & Vérin, M. (2006). La maladie de Parkinson. Monographies en neurologie. Masson, Paris.
Defebvre, L. (2007). La maladie de Parkinson et les syndromes parkinsoniens apparentés. Médecine Nucléaire, 31, 304-313.
Drijgers, R.L., Dujardin, K., Reijnders, J.S.A.M., Defebvre, L., Leentjens, A.F.G. (2010). Validation of diagnostic criteria for apathy in Parkinson’s disease. Parkinsonism and Related Disorders; 16: 656-660.
Dujardin, K. (2007). Apathie et pathologies neuro-dégénératives : physiopathologie, évaluation diagnostique et traitement. Revue Neurologique ; 163, 5 : 513-521.
Dujardin, K., Sockeel, P., Devos, D., Delliaux, M., Krystkowiak, P., Destée, A., Defebvre, L. (2007). Characteristics of apathy in Parkinson’s disease. Movement Disorders ; Vol.22, No.6 : 778-784.
Dujardin K., Defebvre L. (2008). Neuropsychologie de la maladie de Parkinson et des syndromes apparentés. Masson.
Fahn, S., Jankovic, J. (2007). Principles and practice of movement disorders. Churchill Livingstone Elsevier, Philadelphia.
Funkiewiez, A., Ardouin, C. (2005). Intérêt de l’examen neuropsychologique dans le diagnostic différentiel des syndromes parkinsoniens. La lettre du neurologue ; Vol. 9, No. 8 : 1-2.
Janvin, C.C., Psych, M., Larsen, J.P., Aarsland, D., Hugdahl, K., Psych, M. (2006). Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia. Movement Disorders; Vol. 21, No. 9: 1343-1349.
Leentjens, A.F.G., Dujardin, K., Marsh, L., Martinez-Martin, P., Richard, I.H., Starkstein, S.E., Weintraub, D., Sampaio, C., Poewe, W., Rascol, O., Stebbins, G.T., Goetz, C.G. (2008). Anxiety rating scales in Parkinson’s disease: critique and recommendations. Movement Disorders, Vol. 23, No. 14, 2015-2025.
Leentjens, A.F.G., Dujardin, K., Marsh, L., Martinez-Martin, P., Richard, I.H., Starkstein, S.E., Weintraub, D., Sampaio, C., Poewe, W., Rascol, O., Stebbins, G.T., Goetz, C.G. (2008). Apathy and anhedonia rating scales in Parkinson’s disease: critique and recommendations. Movement Disorders, Vol. 23, No. 14, 2004-2014.
Mahieux, F. & Fenelon, G. (2006). Les démences de la maladie de Parkinson. In : Belin, C., Ergis, AM., Moreaud, O. Actualités sur les démences : aspects cliniques et neuropsychologiques. Marseille : Eds Solal.
Mamikonyan, E., Moberg, P.J., Siderowf, A., Duda, J.E., Have, T.T., Hurtig, H.I., Stern, M.B., Weintraub, B. (2009). Mild cognitive impairment is common in Parkinson’s disease patients with normal Mini Mental State Examination (MMSE) scores. Parkinsonism and Related Disorders; 15: 226-231.
Pillon, B., Dubois, B., Agid, Y. (1996). Testing cognition may contribute to the diagnosis of movement disorders. Neurology; Vol. 46, No. 2: 329-334.
Pontone, G.M., Williams, J.R., Anderson, K.E., Chase, G., Goldstein, S.A., Grill, S., Hirsch, E.S., Lehmann, S., Little, J.T., Margolis, R.L., Rabins, P.V., Weiss, H.D., Marsh, L. (2009). Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson’s disease. Movement Disorders; Vol. 24, No. 9: 1333-1338.
Rodriguez-Ferreiro, J., Cuetos, F., Herrera, E., Menendez, M., Ribacoba, R. (2010). Cognitive impairment in Parkinson’s disease without dementia. Movement Disorders ; Vol. 25, No. 13: 2136-2141.
Thobois, S., Ardouin, C., Schmitt, E., Lhommée, E., Klinger, H., Xie, J., Lagrange, C., Kistner, A., Aya Kombo, M., Fleury, V., Poisson, A., Fraix, V., Broussolle, E., Pollak, P., Krack, P. (2010). Maladie de Parkinson: de la physiopathologie des troubles psychiques à la maîtrise du traitement dopaminergique. Revue Neurologique ; 166 : 816-821.
Trail M., Protas E., Lai E. (2008). Neurorehabilitation in Parkinson’s disease, an evidence based-teatment model. Slack incorporated.
Weintraub, D., Moberg, P.J., Culbertson, W.C., Duda, J.E., Katz, I.R., Stern, M.B. (2005). Dimensions of executive function in Parkinson’s disease. Dement Geriatr Cogn Disord; 20: 140-144.